Immunome, Inc. - stock earnings
IMNM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.3 million USD | 3.6 million USD |
| 2023Q2 | -5.6 million USD | 4.3 million USD |
| 2023Q1 | -4.1 million USD | 2.4 million USD |
| 2022Q4 | -8.4 million USD | ? USD |
| 2022Q3 | -8.5 million USD | ? USD |
| 2022Q2 | -8.9 million USD | ? USD |
| 2022Q1 | -11.7 million USD | ? USD |
| 2021Q4 | -7.9 million USD | ? USD |
| 2021Q3 | -7.7 million USD | 6000 USD |
| 2021Q2 | -5.2 million USD | 500000 USD |
| 2021Q1 | -3.9 million USD | ? USD |
| 2020Q4 | -4.1 million USD | ? USD |
| 2020Q3 | -8.4 million USD | ? USD |
| 2020Q2 | -2.7 million USD | ? USD |
| 2020Q1 | -2.7 million USD | ? USD |
| 2019Q4 | -2.9 million USD | ? USD |
| 2019Q3 | -2.7 million USD | ? USD |
IMNM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.0 million USD | 10.2 million USD |
| 2022 | -37.5 million USD | 6.6 million USD |
| 2021 | -24.5 million USD | ? USD |
| 2020 | -17.1 million USD | ? USD |
| 2019 | -10.6 million USD | ? USD |
| 2018 | -7.8 million USD | ? USD |
IMNM
Price: $15.89
52 week price:
Earnings Per Share: -1.80 USD
P/E Ratio: -12.84
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 8759
Market Capitalization: 1.2 billion